NASDAQ: SEER
Seer, Inc.
Healthcare · Biotechnology
Market Cap
$112.44M
52w High
$2.41
52w Low
$1.55
P/E
-1.67
Volume
71.91K
Outstanding Shares
54.98M
Performance
Return analysis
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 0.24% over the last year. Revenue declined 13.26% over the trailing twelve months. Operating margin moved from -558.15% to -511.39%. Free cash flow grew 18.89% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at -511.39%. A decisive move in revenue — currently down 13.26% — would be the clearest signal to resolve the ambiguity.
Company profile
Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
1
Buy
2
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 5, 2026
Q4 FY26 · EPS est -$0.26 · Revenue est $4.15M
View